Clinical Trials
Clinical Trial Detail
Return to search results.
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Complete title: Longitudinal Study of Immune Mediated Disorders after Allogeneic HCT
| Research Study Number | 2342.00 | ||
| Principal Investigator | Stephanie Lee, MD, MPH | ||
| Phase | NA |
Research Study Description
The purpose of this research study is to better understand the onset and course of graft versus host disease (GVHD) after stem cell transplant.
Eligibility Criteria (must meet the following to participate in this study)
- Planned or completed first allogeneic stem cell transplant (any conditioning regimen, graft source, donor type and GVHD prophylaxis regimen)
- Signed, informed consent and, if applicable, child assent
Other eligibility criteria may apply.
Exclusions (conditions that would prevent participation in this study)
- Anticipated survival less than 6 months due to co-morbid disease
- Autoimmune disorder or inherited immunodeficiency before HCT
- Hematologic relapse or chemotherapy refractory disease at restaging within 1 month of HCT or at the time of enrollment (e.g., > 5% blasts for leukemia; poorly responsive lymphoma)
Other exclusion criteria may apply.
|
Keywords
Systemic Sclerosis; Chronic Graft Versus Host Disease (cGVHD); Bronchioloalveolar Carcinoma (BAC)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.
- Diseases
& Research
- Treatment
& Support
- About Us
- Labs &
Projects
- Events &
Community Programs
- How You
Can Help Us
The Hutchinson Center's world-renowned scientists are discovering new ways to detect, prevent and treat cancer, HIV/AIDS and many other diseases.
- License Our Discoveries
The Hutchinson Center's world-renowned researchers work together to pursue lifesaving therapies that will help eliminate cancer and related diseases.
The Hutchinson Center's clinical research breakthroughs are delivered to patients through our treatment arm, the Seattle Cancer Care Alliance. This collaboration combines the strengths of the Hutchinson Center, UW Medicine and Seattle Children's.
You can help eliminate cancer and related diseases by attending Hutchinson Center events and participating in our other fundraising and community efforts.
- Divisions
The Hutchinson Center's pioneering researchers push the boundaries of science to find new ways to prevent, detect and treat cancer and related diseases.
Private support is critical to fund new research ideas and innovations, accelerating our ability to make lifesaving discoveries.
